文献速递妇科

低危早期宫颈癌患者微创手术与开腹子宫切除术的肿瘤学结局:基于SHAPE试验入选标准对KGOG 1028数据的回顾性分析

Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria.
PubMed 文献 · Gynecol Oncol · 2025-04-30

本研究基于韩国妇科肿瘤学组(KGOG)1028队列回顾性分析508例符合SHAPE试验标准的2009 FIGO IB1期宫颈癌患者,比较微创手术(MIS,82例)与开腹子宫切除术(426例)的肿瘤学结局。MIS组无病生存期(DFS)中位55.4个月 vs 开腹组66.5个月(P=0.024),盆腔复发率6.10% vs 1.88%(P=0.024)。多变量Cox回归显示MIS为复发的独立预测因素(HR 3.26,95%CI 1.054-10.061,P=0.040)。

要点

  • 符合SHAPE标准的低危早期宫颈癌中,MIS组DFS中位55.4个月,短于开腹组的66.5个月(P=0.024)。
  • MIS组盆腔复发率6.10%,高于开腹组的1.88%(P=0.024)。
  • 多变量分析中MIS为复发独立预测因素(HR 3.26,95%CI 1.054-10.061,P=0.040)。

核心结论

  • 在符合SHAPE试验标准的低危早期宫颈癌患者中,MIS与较短的DFS和较高的盆腔复发风险相关,与LACC试验提出的担忧一致,提示MIS可能存在肿瘤学劣势。
  • 作者认为需要进一步开展前瞻性随机研究,采用标准化的患者选择来验证这些结果并指导决策。

研究设计与样本

  • 回顾性研究,分析韩国妇科肿瘤学组(KGOG)1028队列数据,纳入符合SHAPE试验标准并接受MIS或开腹子宫切除术的2009 FIGO IB1期宫颈癌患者。
  • 共纳入508例患者,其中MIS组82例,开腹子宫切除术组426例。
  • 主要结局为无病生存期(DFS),次要结局包括盆腔复发率和影响DFS的预后因素。

主要发现

  • MIS组DFS中位55.4个月 vs 开腹子宫切除术组66.5个月(P=0.024),MIS组显著缩短。
  • MIS组盆腔复发率6.10% vs 开腹子宫切除术组1.88%(P=0.024),MIS组更高。
  • 多变量Cox回归分析显示MIS为复发的独立预测因素(HR 3.26;95%CI 1.054-10.061;P=0.040)。
  • 多变量Cox回归分析显示肿瘤较大为复发的独立预测因素(每增加1 cm,HR 3.65;95%CI 1.300-9.854;P=0.011)。
  • 多变量Cox回归分析显示年龄较大为复发的独立预测因素(每增加1岁,HR 1.05;95%CI 1.002-1.096;P=0.043)。

临床怎么用

  • 原文结论指出,即使符合SHAPE试验标准的低危早期宫颈癌患者,MIS与开腹子宫切除术相比仍与较短的DFS和较高的盆腔复发风险相关,作者认为需要进一步前瞻性随机研究验证并指导决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the oncologic outcomes of minimally invasive surgery (MIS) and abdominal hysterectomy in patients with low-risk, early-stage cervical cancer, based on the SHAPE trial eligibility criteria. METHODS: This retrospective study analyzed data from the Korean Gynecologic Oncology Group (KGOG) 1028 cohort, including patients with 2009 FIGO stage IB1 cervical cancer who met SHAPE trial criteria and underwent MIS or abdominal hysterectomy. Disease-free survival (DFS) was the primary outcome, whereas secondary outcomes included pelvic recurrence rates and prognostic factors influencing DFS. RESULTS: A total of 508 patients were included (82 in the MIS group and 426 in the abdominal hysterectomy group). The MIS group had significantly shorter DFS (median, 55.4 vs. 66.5 months, P = 0.024) and a higher pelvic recurrence rate (6.10 % vs. 1.88 %, P = 0.024). Multivariable Cox regression analysis identified MIS as an independent predictor of recurrence (HR, 3.26; 95 % CI, 1.054-10.061; P = 0.040), along with a larger tumor size (HR, 3.65 per 1 cm increase; 95 % CI, 1.300-9.854; P = 0.011) and older age (HR, 1.05 per year; 95 % CI, 1.002-1.096; P = 0.043). CONCLUSIONS: Even in low-risk, early-stage cervical cancer patients meeting SHAPE trial criteria, MIS was associated with shorter DFS and a higher pelvic recurrence risk than abdominal hysterectomy. These findings are consistent with concerns raised by the LACC trial, suggesting a potential oncologic disadvantage of MIS. Further prospective, randomized studies with standardized patient selection are needed to validate these results and guide decision-making.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bae J, Kim U, Paik ES, et al. Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria. Gynecol Oncol. 2025. PMID: 40311526. doi:10.1016/j.ygyno.2025.04.582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。